Abstract
According to a compelling body of evidence anesthetic preconditioning (APC) attenuates the deleterious consequences of ischemia–reperfusion and protects the heart through a mechanism similar to ischemic preconditioning. The present study was purported to investigate the intracellular signaling pathways activated in human myocardium in response to a preconditioning protocol with two different volatile anesthetics, namely isoflurane and sevoflurane. To this aim, phosphorylation of PKCα and -δ, ERK1/2, Akt, and GSK3β was determined at the end of the APC protocol, in human atrial samples harvested from patients undergoing open-heart surgery. The results demonstrate that preconditioning with volatile anesthetics triggers the activation of PKCδ and -α isoforms and of prosurvival kinases, ERK1/2, and Akt, while inhibiting their downstream target GSK3β during the memory phase.
Similar content being viewed by others
References
Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74(5):1124–1136
Iliodromitis EK, Lazou A, Kremastinos DT (2007) Ischemic preconditioning: protection against myocardial necrosis and apoptosis. Vasc Health Risk Manag 3(5):629–637
Hausenloy DJ, Yellon DM (2011) The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol 8(11):619–629
Riess ML, Stowe DF, Warltier DC (2004) Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside? Am J Physiol Heart Circ Physiol 286(5):H1603–H1607
De Hert SG, Preckel B, Hollmann MW, Schlack WS (2009) Drugs mediating myocardial protection. Eur J Anaesthesiol 26(12):985–995
Lorsomradee S, Cromheecke S, Lorsomradee S, De Hert SG (2008) Cardioprotection with volatile anesthetics in cardiac surgery. Asian Cardiovasc Thorac Ann 16(3):256–264
Pagel PS (2013) Myocardial protection by volatile anesthetics in patients undergoing cardiac surgery: a critical review of the laboratory and clinical evidence. J Cardiothorac Vasc Anesth 27(5):972–982
Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM (2005) Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol 288:H971–H976
Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC (2004) Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 100(3):707–721
Pratt PF Jr, Wang C, Weihrauch D, Bienengraeber MW, Kersten JR, Pagel PS, Warltier DC (2006) Cardioprotection by volatile anesthetics: new applications for old drugs? Curr Opin Anaesthesiol 19(4):397–403
Fryer RM, Schultz JE, Hsu AK, Gross GJ (1999) Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol 276(4 Pt 2):H1229–H1235
Obal D, Weber NC, Zacharowski K, Toma O, Dettwiler S, Wolter JI, Kratz M, Müllenheim J, Preckel B, Schlack W (2005) Role of protein kinase C-epsilon (PKCepsilon) in isoflurane-induced cardioprotection. Br J Anaesth 94(2):166–173
Lange M, Redel A, Smul TM, Lotz C, Nefzger T, Stumpner J, Blomeyer C, Gao F, Roewer N, Kehl F (2009) Desflurane-induced preconditioning has a threshold that is lowered by repetitive application and is mediated by beta 2-adrenergic receptors. J Cardiothorac Vasc Anesth 23(5):607–613. doi:10.1053/j.jvca.2009.01.016
Frässdorf J, Borowski A, Ebel D, Feindt P, Hermes M, Meemann T, Weber R, Müllenheim J, Weber NC, Preckel B, Schlack W (2009) Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery. J Thorac Cardiovasc Surg 137(6):1436–1442
Aizawa K, Turner LA, Weihrauch D, Bosnjak ZJ, Kwok WM (2004) Protein kinase C-epsilon primes the cardiac sarcolemmal adenosine triphosphate sensitive potassium channel to modulation by isoflurane. Anesthesiology 101(2):381–389
Pravdic D, Sedlic F, Mio Y, Vladic N, Bienengraeber M, Bosnjak ZJ (2009) Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein kinase C-epsilon-mediated pathway. Anesthesiology 111(2):267–274
Okusa C, Miyamae M, Sugioka S, Kaneda K, Inamura Y, Onishi A, Domae N, Kotani J, Figueredo VM (2009) Acute memory phase of sevoflurane preconditioning is associated with sustained translocation of protein kinase C-alpha and epsilon, but not delta, in isolated guinea pig hearts. Eur J Anaesthesiol 26(7):582–588
Parekh DB, Katso RM, Leslie NR, Downes CP, Procyk KJ, Waterfield MD, Parker PJ (2000) Beta1-integrin and PTEN control the phosphorylation of protein kinase C. Biochem J 352(Pt 2):425–433
Konishi H, Yamauchi E, Taniguchi H, Yamamoto T, Matsuzaki H, Takemura Y, Ohmae K, Kikkawa U, Nishizuka Y (2001) Phosphorylation sites of protein kinase C delta in H2O2-treated cells and its activation by tyrosine kinase in vitro. Proc Natl Acad Sci USA 98(12):6587–6592
Hausenloy DJ, Yellon DM (2007) Reperfusion injury salvage kinases signaling: taking a RISK for cardioprotection. Heart Fail Rev 12(3–4):217–234
Symons JA, Myles PS (2006) Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth 97:127–136
Zaugg M, Lucchinetti E, Uecker M, Pasch T, Schaub MC (2003) Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth 91(4):551–565
Muntean DM, Ordodi V, Ferrera R, Angoulvant D (2013) Volatile anesthetics and cardioprotection: lessons from animal studies. Fundam Clin Pharmacol 27(1):21–34
Yu CH, Beattie WS (2006) The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can J Anaesth 53:906–918
Tomai F, De Paulis R, Penta de Peppo A, Colagrande L, Caprara E, Polisca P, De Matteis G, Ghini AS, Forlani S, Colella D, Chiariello L (1999) Beneficial impact of isoflurane during coronary bypass surgery on troponin I release. G Ital Cardiol 29(9):1007–1017
Piriou V, Mantz J, Goldfarb G, Kitakaze M, Chiari P, Paquin S, Cornu C, Lecharny JB, Aussage P, Vicaut E, Pons A, Lehot JJ (2007) Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial. Br J Anaesth 99(5):624–631
Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasché P (1999) Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 100(19 Suppl):II340–II344
Meco M, Cirri S, Gallazi C, Magnani G, Cosetta D (2007) Desflurane preconditioning in coronary artery bypass graft surgery: a double blinded, randomized and placebo-controlled study. Eur J Cardiothor Surg 32(2):319–325
Amr YM, Yassin IM (2010) Cardiac protection during on-pump coronary artery bypass grafting: ischemic versus isoflurane preconditioning. Semin Cardiothorac Vasc Anesth 14(3):205–211
Tanno M, Tsuchida A, Nozawa Y, Matsumoto T, Hasegawa T, Shimamoto K (2000) Roles of tyrosine kinase and protein kinase C in infarct size limitation by repetitive ischemic preconditioning in the rat. J Cardiovasc Pharmacol 35(3):345–352
Fradorf J, Huhn R, Weber NC, Ebel D, Wingert N, Preckel B, Toma O, Schlack W, Hollmann MW (2010) Sevoflurane-induced preconditioning: impact of protocol and aprotinin administration on infarct size and endothelial NO synthase phosphorylation in the rat heart in vivo. Anesthesiology 113(6):1289–1298
de Ruijter W, Musters RJ, Boer C, Stienen GJ, Simonides WS, de Lange JJ (2003) The cardioprotective effect of sevoflurane depends on protein kinase C activation, opening of mitochondrial K(+)(ATP) channels, and the production of reactive oxygen species. Anesth Analg 97(5):1370–1376
Novalija E, Kevin LG, Camara AK, Bosnjak ZJ, Kampine JP, Stowe DF (2003) Reactive oxygen species precede the epsilon isoform of PKC in the anesthetic preconditioning signaling cascade. Anesthesiology 99(2):421–428
Pravdic D, Sedlic F, Mio Y, Vladic N, Bienengraeber M, Bosnjak ZJ (2009) Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein Kinase C-epsilon-mediated pathway. Anesthesiology 111(2):267–274
Bouwman RA, Musters RJ, van Beek-Harmsen BJ, de Lange JJ, Boer C (2004) Reactive oxygen species precede PKC delta activation independent of ATP sensitive mitochondrial channel opening in sevoflurane-induced cardioprotection. Anesthesiology 100(3):506–514
Bouwman RA, Musters RJ, van Beek-Harmsen BJ, de Lange JJ, Lamberts RR, Loer SA, Boer C (2007) Sevoflurane-induced cardioprotection depends on PKC-alpha activation via production of reactive oxygen species. Br J Anaesth 99(5):639–645
Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, Zaugg M (2003) Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 98(6):1315–1327
Hassouna A, Matata BM, Galiñanes M (2004) PKC-epsilon is upstream and PKC-alpha is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium. Am J Physiol Cell Physiol 287(5):C1418–C1425
Tsouka V, Markou T, Lazou A (2002) Differential effect of ischemic and pharmacological preconditioning on PKC isoform translocation in adult rat cardiac myocytes. Cell Physiol Biochem 12(5–6):315–324
Sivaraman V, Hausenloy DJ, Kolvekar S, Hayward M, Yap J, Lawrence D, Di Salvo C, Yellon DM (2009) The divergent roles of protein kinase C epsilon and delta in simulated ischaemia-reperfusion injury in human myocardium. J Mol Cell Cardiol 46(5):758–764
Da Silva R, Grampp T, Pasch T, Schaub MC, Zaugg M (2004) Differential activation of mitogen-activated protein kinases in ischemic and anesthetic preconditioning. Anesthesiology 100(1):59–69
Toma O, Weber NC, Wolter JI, Obal D, Preckel B, Schlack W (2004) Desflurane preconditioning induces time-dependent activation of protein kinase C epsilon and extracellular signal-regulated kinase 1 and 2 in the rat heart in vivo. Anesthesiology 101(6):1372–1380
Raphael J, Rivo J, Gozal Y (2005) Isoflurane-induced myocardial preconditioning is dependent on phosphatidylinositol-3-kinase/Akt signalling. Br J Anaesth 95(6):756–763
Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, Sollott SJ (2004) Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113(11):1535–1549
Andrews DT, Royse C, Royse AG (2012) The mitochondrial permeability transition pore and its role in anaesthesia-triggered cellular protection during ischaemia-reperfusion injury. Anaesth Intensive Care 40(1):46–70
Feng J, Lucchinetti E, Ahuja P, Pasch T, Perriard JC, Zaugg M (2005) Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase beta. Anesthesiology 103(5):987–995
Fang NX, Yao YT, Shi CX, Li LH (2010) Attenuation of ischemia-reperfusion injury by sevoflurane postconditioning involves proteinkinase B and glycogen synthase kinase 3 beta activation in isolated hearts. Mol Biol Rep 7(8):3763–3769
Acknowledgments
Technical support of Drs. Radu Scarlat and Cristian Boros is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Additional information
Kyriakos Mellidis and Valentin Ordodi have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Mellidis, K., Ordodi, V., Galatou, E. et al. Activation of prosurvival signaling pathways during the memory phase of volatile anesthetic preconditioning in human myocardium: a pilot study. Mol Cell Biochem 388, 195–201 (2014). https://doi.org/10.1007/s11010-013-1910-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-013-1910-5